Spieth Peter M, Güldner Andreas, Uhlig Christopher, Bluth Thomas, Kiss Thomas, Schultz Marcus J, Pelosi Paolo, Koch Thea, Gama de Abreu Marcelo
Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Medicine, University Hospital Dresden, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
Trials. 2014 May 2;15:155. doi: 10.1186/1745-6215-15-155.
General anesthesia usually requires mechanical ventilation, which is traditionally accomplished with constant tidal volumes in volume- or pressure-controlled modes. Experimental studies suggest that the use of variable tidal volumes (variable ventilation) recruits lung tissue, improves pulmonary function and reduces systemic inflammatory response. However, it is currently not known whether patients undergoing open abdominal surgery might benefit from intraoperative variable ventilation.
METHODS/DESIGN: The PROtective VARiable ventilation trial ('PROVAR') is a single center, randomized controlled trial enrolling 50 patients who are planning for open abdominal surgery expected to last longer than 3 hours. PROVAR compares conventional (non-variable) lung protective ventilation (CV) with variable lung protective ventilation (VV) regarding pulmonary function and inflammatory response. The primary endpoint of the study is the forced vital capacity on the first postoperative day. Secondary endpoints include further lung function tests, plasma cytokine levels, spatial distribution of ventilation assessed by means of electrical impedance tomography and postoperative pulmonary complications.
We hypothesize that VV improves lung function and reduces systemic inflammatory response compared to CV in patients receiving mechanical ventilation during general anesthesia for open abdominal surgery longer than 3 hours. PROVAR is the first randomized controlled trial aiming at intra- and postoperative effects of VV on lung function. This study may help to define the role of VV during general anesthesia requiring mechanical ventilation.
Clinicaltrials.gov NCT01683578 (registered on September 3 3012).
全身麻醉通常需要机械通气,传统上是在容量控制或压力控制模式下采用恒定潮气量来实现。实验研究表明,使用可变潮气量(可变通气)可使肺组织复张,改善肺功能并减轻全身炎症反应。然而,目前尚不清楚接受开腹手术的患者是否能从术中可变通气中获益。
方法/设计:保护性可变通气试验(“PROVAR”)是一项单中心随机对照试验,招募50例计划接受预计持续时间超过3小时的开腹手术患者。PROVAR就肺功能和炎症反应方面,将传统(非可变)肺保护性通气(CV)与可变肺保护性通气(VV)进行比较。该研究的主要终点是术后第一天的用力肺活量。次要终点包括进一步的肺功能测试、血浆细胞因子水平、通过电阻抗断层扫描评估的通气空间分布以及术后肺部并发症。
我们假设,在接受全身麻醉、机械通气超过3小时的开腹手术患者中,与CV相比,VV可改善肺功能并减轻全身炎症反应。PROVAR是第一项针对VV对肺功能的术中及术后影响的随机对照试验。本研究可能有助于明确VV在需要机械通气的全身麻醉过程中的作用。
Clinicaltrials.gov NCT01683578(于2012年9月3日注册)。